CLOSTRIDIOIDES DIFFICILE INFECTION

This study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days, and researchers w…

This study tests whether xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low dose, high dose, or placebo capsule for 4 weeks. Researchers…

This early-stage trial tests whether xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take xylitol by mouth, and researchers will check if the infection…

This early-phase trial tests whether adding ursodeoxycholic acid (UDCA) to standard antibiotics can prevent Clostridioides difficile (C. diff) infection from returning. About 30 adults with C. diff and risk factors for recurrence will take UDCA three times daily for up to 8 weeks…

This study looks at adults who had a C. diff infection and were treated with either a fecal transplant (FMT) or antibiotics alone. Researchers want to see if FMT leads to healthier gut bacteria and better long-term health up to 10 years later. Participants provide blood, stool, u…